GSK Statistics

Share Statistics

GSK has 2.02B shares outstanding. The number of shares has increased by 0.4% in one year.

Shares Outstanding	2.02B
Shares Change (YoY)	0.4%
Shares Change (QoQ)	0.67%
Owned by Institutions (%)	8.95%
Shares Floating	1.96B
Failed to Deliver (FTD) Shares	22,912
FTD / Avg. Volume	0.43%

Short Selling Information

The latest short interest is 13.51M, so 0.67% of the outstanding shares have been sold short.

Short Interest	13.51M
Short % of Shares Out	0.67%
Short % of Float	0.67%
Short Ratio (days to cover)	2.56

Valuation Ratios

The PE ratio is 21.39 and the forward PE ratio is 9.69. GSK's PEG ratio is -0.44.

PE Ratio	21.39
Forward PE	9.69
PS Ratio	1.76
Forward PS	1.7
PB Ratio	4.03
P/FCF Ratio	15.42
PEG Ratio	-0.44

Financial Ratio History

Enterprise Valuation

GSK has an Enterprise Value (EV) of 123.47B.

EV / Sales	3.94
EV / EBITDA	18.52
EV / EBIT	18.84
EV / FCF	34.57

Financial Position

The company has a current ratio of 0.78, with a Debt / Equity ratio of 1.24.

Current Ratio	0.78
Quick Ratio	0.52
Debt / Equity	1.24
Debt / EBITDA	2.55
Debt / FCF	4.76
Interest Coverage	6.28

Financial Efficiency

Return on Equity is 18.84% and Return on Invested Capital is 8.51%.

Return on Equity	18.84%
Return on Assets	4.33%
Return on Invested Capital	8.51%
Revenue Per Employee	$457.18K
Profits Per Employee	$37.52K
Employee Count	68,629
Asset Turnover	0.53
Inventory Turnover	1.6

Taxes

Income Tax	526M
Effective Tax Rate	15.13%

Stock Price Statistics

The stock price has increased by -6.42% in the last 52 weeks. The beta is 0.27, so GSK's price volatility has been higher than the market average.

Beta	0.27
52-Week Price Change	-6.42%
50-Day Moving Average	38.82
200-Day Moving Average	36.91
Relative Strength Index (RSI)	49.56
Average Volume (20 Days)	5,291,154

Income Statement

In the last 12 months, GSK had revenue of 31.38B and earned 2.58B in profits. Earnings per share was 1.26.

Revenue	31.38B
Gross Profit	22.33B
Operating Income	4.02B
Net Income	2.58B
EBITDA	6.67B
EBIT	4.12B
Earnings Per Share (EPS)	1.26

Full Income Statement

Balance Sheet

The company has 3.69B in cash and 16.99B in debt, giving a net cash position of -13.29B.

Cash & Cash Equivalents	3.69B
Total Debt	16.99B
Net Cash	-13.29B
Retained Earnings	7.8B
Total Assets	59.26B
Working Capital	-2.71B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.55B and capital expenditures -2.98B, giving a free cash flow of 3.57B.

Operating Cash Flow	6.55B
Capital Expenditures	-2.98B
Free Cash Flow	3.57B
FCF Per Share	1.75

Full Cash Flow Statement

Margins

Gross margin is 71.16%, with operating and profit margins of 12.82% and 8.21%.

Gross Margin	71.16%
Operating Margin	12.82%
Pretax Margin	11.08%
Profit Margin	8.21%
EBITDA Margin	21.25%
EBIT Margin	12.82%
FCF Margin	11.38%

Dividends & Yields

GSK pays an annual dividend of $2.03, which amounts to a dividend yield of 4.34%.

Dividend Per Share	$2.03
Dividend Yield	4.34%
Dividend Growth (YoY)	-1.33%
Payout Ratio	90%
Earnings Yield	4.67%
FCF Yield	3.24%

Dividend Details

Analyst Forecast

The average price target for GSK is $47, which is 24.6% higher than the current price. The consensus rating is "Hold".

Price Target	$47
Price Target Difference	24.6%
Analyst Consensus	Hold
Analyst Count	4

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	$6.3
Lynch Upside	-83.3%
Graham Number	6.9
Graham Upside	-81.71%

Stock Splits

The last stock split was on Jul 22, 2022. It was a forward split with a ratio of 613:500.

Last Split Date	Jul 22, 2022
Split Type	forward
Split Ratio	613:500

Scores

Altman Z-Score	2
Piotroski F-Score	8

GSK (GSK)